Celgene Corp (CELG)

145.95
2.10 1.40
NASDAQ : Health Care
Prev Close 143.89
Open 143.89
Day Low/High 143.69 / 144.90
52 Wk Low/High 92.98 / 137.54
Volume 339.44K
Avg Volume 3.36M
Exchange NASDAQ
Shares Outstanding 782.35M
Market Cap 112.49B
EPS 2.60
P/E Ratio 44.65
Div & Yield N.A. (N.A)

Latest News

Celgene Provides Update On The Fusion™ Clinical Program

Celgene Provides Update On The Fusion™ Clinical Program

Celgene Corporation (NASDAQ:CELG) today announced that the U.S.

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

More Immunotherapy Buyouts Likely After Kite Sale

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Jim Cramer takes his stock picks -- like his fantasy football picks -- very, very seriously.

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks

This team is playoff-ready and built for the ages.

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap (Wed 8/30/17)

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap (Wed 8/30/17)

From political signals to the rebuilding and recovery efforts in Texas, Jim Cramer says investors should pay attention to what's supporting stocks.

Cramer: There Should Be More Takeovers Where These Came From

Cramer: There Should Be More Takeovers Where These Came From

Buying's good for the acquirers, which should give other companies ideas.

Biotech M&A: Who's Next After Gilead-Kite?

Biotech M&A: Who's Next After Gilead-Kite?

Prospects for acquisition activity in the sector are improving.

Celgene Corporation To Webcast At Upcoming Investor Conferences

Celgene Corporation To Webcast At Upcoming Investor Conferences

Celgene Corporation (NASDAQ:CELG) plans to present at four upcoming investor conferences where Celgene management will provide an overview of the Company.

Cramer: Random Movement Is Exactly That

Cramer: Random Movement Is Exactly That

Nothing's happening, but that doesn't mean you have to make something happen.

Be Cautious in Case of a Second-Half Hiccup

Be Cautious in Case of a Second-Half Hiccup

The market seems fully valued, so I'm building up cash as we head into historically volatile months.

Back to Basics in Biotech

Back to Basics in Biotech

Stop losses do not work in this part of the market.

Back to Basics in Biotech

Back to Basics in Biotech

Stop losses do not work in this part of the market.

Looking to Buy Some Celgene? Now's a Good Time

Looking to Buy Some Celgene? Now's a Good Time

CELG looks like it has a promising future, according to the charts.

(Graphic: Business Wire)

(Graphic: Business Wire)

Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced that IDHIFA ® (enasidenib) was granted approval from the U.

Here's Why I'm Valuing Value Over Growth

Here's Why I'm Valuing Value Over Growth

Multiples have become quite rich and dysfunction in Washington could end up biting the markets.

Celgene Corporation To Webcast At Upcoming Investor Conference

Celgene Corporation To Webcast At Upcoming Investor Conference

Celgene Corporation (NASDAQ:CELG) plans to present at an upcoming investor conference where Celgene management will provide an overview of the Company.

Nasdaq Tumbles as Tech Takes a Turn Lower

Nasdaq Tumbles as Tech Takes a Turn Lower

The Nasdaq tumbles and the S&P 500 slides. The Dow rises slightly.

Wall Street Trades at Records as Facebook Rallies

Wall Street Trades at Records as Facebook Rallies

Stocks are higher.

Stock Futures Power Higher on Earnings Beat From Facebook

Stock Futures Power Higher on Earnings Beat From Facebook

Stock futures are higher.

Celgene Reports Second Quarter 2017 Operating And Financial Results

Celgene Reports Second Quarter 2017 Operating And Financial Results

Celgene Corporation (NASDAQ:CELG) reported net product sales of $3,256 million for the second quarter of 2017, a 19 percent increase from the same period in 2016.

Facebook on Fire - 5 Things You Must Know Before the Market Opens Thursday

Facebook on Fire - 5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures point higher after Facebook shares jump.

Celgene Corporation Announces Settlement Of Civil Litigation

Celgene Corporation Announces Settlement Of Civil Litigation

Celgene Corporation (NASDAQ:CELG) today announced that it has reached a civil settlement with Relator Brown, the Department of Justice, 28 States, the District of Columbia, and the City of Chicago to resolve the previously...

Celgene Settles 'Whistle Blower' Lawsuit for $280 Million

Celgene Settles 'Whistle Blower' Lawsuit for $280 Million

Celgene had been accused of marketing off-label uses for two of its cancer treatments.

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog

Stock prices are either unfairly dragged down by competitors' earnings news or by Amazon's spread into more businesses, Cramer said.

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

Wall Street's first glimpse at the second quarter.

Cramer: Rotations Hit Companies That Don't Deserve It

Cramer: Rotations Hit Companies That Don't Deserve It

Case in point: Home Depot and Lowe's.

These Are the Best Growth Stocks Right Now in Biotech

These Are the Best Growth Stocks Right Now in Biotech

Top names.

Risk Happens Fast: Doug Kass

Risk Happens Fast: Doug Kass

What you need to know.

TheStreet Quant Rating: A (Buy)